Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Onychomycosis Treatment Market
Onychomycosis Treatment Market Size
- Report ID: GMI5089
- Published Date: Aug 2021
- Report Format: PDF
Onychomycosis Treatment Market Size
Onychomycosis Treatment Market size exceeded USD 4.2 billion in 2020 and is expected to grow at a CAGR of over 5.6% from 2021 to 2027. Increasing prevalence of onychomycosis worldwide, growing awareness about the potential threats of onychomycosis, and the rise in the adoption of drug therapies are some of the prominent factors that drive the market growth. Moreover, rising cases of age-related onychomycosis will further propel the market expansion during the forecast period.
The impact of COVID-19 on the market is observed to be negative since a large number of countries adopted lockdown to curb community transmission of the COVID-19 infection. The market witnessed a short-term disruption during the initial days of the COVID-19 pandemic due to the supply chain disruptions and decline in non-urgent in-person clinic visits resulting in a negative impact on the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2020 |
| Onychomycosis Treatment Market Size in 2020: | 4.2 Billion (USD) |
| Forecast Period: | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR: | 5.6% |
| 2027 Value Projection: | 6.2 Billion (USD) |
| Historical Data for: | 2016 to 2020 |
| No. of Pages: | 130 |
| Tables, Charts & Figures: | 134 |
| Segments covered: | Type, Treatment Type, Drug Class, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Onychomycosis Treatment Market Scope
